Item 5.02         Departure of Directors or Certain Officers; Election of Directors;
                  Appointment of Certain Officers; Compensatory Arrangements of Certain
                  Officers.

On July 15, 2020, the Board of Directors (the "Board") of NeoGenomics, Inc., a Nevada corporation (the "Company") upon the recommendation of the Nominating and Corporate Governance Committee, voted to appoint Michael A. Kelly to serve as a member of the Board, effective immediately. Mr. Kelly will serve as a member of the Board until the 2021 annual meeting of shareholders of the Company or until his resignation or removal and otherwise until his successor is elected. The Board determined that Mr. Kelly meets the independence standards of the NASDAQ Stock Market Rules and the applicable rules of the United States Securities and Exchange Commission. The Board also appointed Mr. Kelly to serve on the Audit Committee of the Board. Mr. Kelly will receive quarterly fees of $11,250, for his service on the Board and quarterly fees of $2,500 for his service on the Audit Committee. There is no arrangement pursuant to which Mr. Kelly was selected as a director, and there have been no transactions regarding Mr. Kelly that are required to be disclosed pursuant to Item 404(a) of Regulation S-K. In addition, Lynn A. Tetrault has been named Lead Independent Director of the Board, effective July 15, 2020. Ms. Tetrault has served on the Board since June 2015 and is Chair of the Board's Compensation Committee. The Board approved Ms. Tetrault to receive an additional quarterly fee of $7,500 for serving as the Lead Independent Director of the Board. Item 9.01 Exhibits.




(d) Exhibits.

99.1 Press Release date d July 20 , 2020 .

© Edgar Online, source Glimpses